Phosphodiesterase Type 5 Inhibition with Tadalafil Changes Outcomes in Heart Failure (PITCH-HF)
Randomized, double blind, Placebo controlled trial to determine the safety, efficacy and effect of Tadalafil (Cialis) on the functional capacity/Quality of Life for patients with left ventricular systolic dysfunction (LVSD), heart failure (HF) and secondary pulmonary hypertension (PH).
This study is sponsored by Massachusetts General Hospital (MGH) and New England Research Institutes, Inc (NERI) grant award from the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH).
Male or female over 21 years of age with LVSD HF and secondary PH. To learn more about Cardiovascular research, click here.